CES (com)vida 2020
We're desperate for a coronavirus cure, but at what cost to the human guinea pigs?
Kenan Malik
The Guardian
Overview
The race for treatments for coronavirus reminds us how the development, by pharmaceutical multinationals, of drugs that will be produced and destined for the populations of the North is increasingly based on a global clinical trial industry for which the global South provides human guinea pigs.
vida/images/29278_photo-1586362102368-7a82b8d2a28e-256x144_v2.jpg)